Il Professore Associato Muhammet Derda Ozer è specializzato in retinoblastoma, con formazione presso il Wills Eye Institute, leader mondiale in oncologia oculare.
Dr. Ceyhun Bozkurt is a pediatric hematologist-oncologist at Medical Park Bahcelievler Hospital. He serves as the clinical director and vice director of the stem cell transplant unit. Dr. Bozkurt focuses on childhood leukemia, bone marrow transplants, and neuroblastoma. He completed specialized observerships at Harvard University and Cincinnati Children's Hospital.
La professoressa Yesim Yildirim è specializzata in immunoterapia del cancro e terapie mirate, con un focus sui tumori al seno, gastrointestinali e polmonari.
Il medico si è laureato presso la Facoltà di Medicina dell'Università di Dicle nel 1984 e ha completato la formazione di specializzazione in Chirurgia Pediatrica presso la stessa istituzione nel 1994. Con un focus sulla chirurgia neonatale, l'urologia pediatrica, la chirurgia oncologica e altro, il medico possiede un Certificato di Qualificazione in Chirurgia Pediatrica Turca dal 2002.<\/p>
Avendo partecipato a numerosi corsi specializzati, tra cui Malformazioni Anorettali e Riparazioni e Corsi Internazionali di Ipospadia, il medico è membro di diverse società professionali come la Società Turca di Chirurgia Pediatrica e la Società di Urologia Pediatrica.<\/p>
Dunyagoz Eye Hospital, Anadolu Medical Center, and Memorial Hospitals are leading Turkish centers for retinoblastoma. These facilities combine pediatric oncology with specialized ophthalmology. Many maintain Joint Commission International (JCI) accreditation. Istanbul and Ankara serve as primary hubs for complex ocular oncology care.
Bookimed Expert Insight: While popular hospital brands attract many patients, the highest value for retinoblastoma often lies with specific ocular specialists like Dr. Muhammet Derda Ozer. His experience of 25,000 surgeries exceeds common benchmarks. Such high caseloads are critical for performing eye-sparing procedures safely.
Patient Consensus: Families often emphasize finding a single system that offers combined pediatric oncology and ocular imaging. They note it is important to confirm a hospital has a dedicated retinoblastoma team before traveling.
Advanced retinoblastoma treatments in Turkey include selective intra-arterial chemotherapy (SIAC), intravitreal chemotherapy, and eye-sparing focal therapies. JCI-accredited centers in Istanbul and Ankara utilize cryotherapy and laser photocoagulation. Specialized surgeons perform enucleation with implant insertion for advanced cases to ensure optimal cosmetic results.
Bookimed Expert Insight: Specialist surgeons in Turkey, such as Dr. Muhammet Derda Ozer or Dr. Ahmet Satici, have performed over 20,000 surgeries each. This high volume is critical for retinoblastoma, where precision in globe-sparing techniques or implant placement directly impacts the child's quality of life. Some packages even include 5 days in a 4-star hotel to accommodate necessary follow-up exams.
Patient Consensus: Parents emphasize looking for centers specifically marketing retinoblastoma services rather than general pediatric care. They suggest budgeting 2–4 weeks for stays as treatment plans often shift rapidly between eye-saving methods and surgery.